glutathione and chemotherapy drugs Glutathione-mediated nanomedicines for cancer diagnosis therapy Frontiers | Glutathione-responsive and -exhausting
Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy LKB1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and irradiation ScienceDirect Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy PMC Glutathione Metabolism an overview ScienceDirect Topics Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17




